Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

These CROs are big and have very large capacity to handle multiple trials. P trial had only 199 patients.
In most cases the data is entered into the tool by sites directly as they have advance tools

The trial had 2 PE and 9 SE - only 1 PE and 4 SE depended on 16 week data. So by the time last patient visit on Dec 21st - most of the 12 week and 16 week data was already collected and available with CRO - and most likely entered into DB.

So the time taken for even giving primary outcome and say whether it met or not is suspiciously long.

Typically most of them issue PE results soon and if good/great, keep secondary and detailed results for scientific conf

In biotech - in my experience -
No news in 80% of the cases is bad news

Simply because tiny biotechs live on positive news cycle and die based on delayed or bad news

It clearly seems to me that P results are not going to be that great and Leo is trying to time it with some alternate news to reduce the blow.

But hey - this is already 40 cent share - it could soon become 10 cent